Similar to rapamycin [32], via blockade of mitochondrial oxidative stress and mTOR [10,33], NAC may have the premise to expand antiviral CD8 T cells and reverse infections [8] and thus potentially expand life-span in SLE [34]. Here, CD8A is linked to systemic lupus erythematosus.